Transplants of fetal dopamine neurons can be used to restore dopamine neurotransmission in animal models of Parkinson's disease, as well as in patients with advanced Parkinson's disease. In these studies the cells are placed in the striatum rather than in the substantia nigra where they normally reside, which may limit their ability to achieve full restoration of motor function. Using a microtransplantation approach, which allows precise placement of small cell deposits directly into the host substantia nigra, and fetal donor cells that express green fluorescent protein under the control of the tyrosine hydroxylase promoter, we show that dopamine neuroblasts implanted into the substantia nigra of adult mice are capable of generating a new nigrostriatal pathway with an outgrowth pattern that matches the anatomy of the intrinsic system. This target-directed regrowth was closely aligned with the intrinsic striatonigral fibre projection and further enhanced by over-expression of glial cell line-derived neurotrophic factor in the striatal target. Results from testing of amphetamine-induced rotational behaviour suggest, moreover, that dopamine neurons implanted into the substantia nigra are also capable of integrating into the host circuitry at the functional level.
Introduction
Cell transplantation in Parkinson's disease is based on the idea that grafted dopamine (DA) neurons can be used to replace the intrinsic nigral DA neurons lost to disease. Clinical trials using transplants of DA neuroblasts, obtained from fetal ventral mesencephalon (VM), have given promising results although the clinical outcome has so far been highly variable (Lindvall & Bjorklund, 2004; Olanow & Fahn, 2006) . In these trials the cells have been implanted into the striatum, i.e. in close proximity to the target cells, rather than in the substantia nigra (SN) where the DA neurons normally reside. DA neurons grafted directly into the striatum are capable of providing an extensive functional reinnervation of the host striatum (Piccini et al., 1999; Mendez et al., 2005) . In this ectopic location, however, the grafts are likely to be deprived of major afferent inputs that may be required for optimal regulation of DA neuron function during ongoing behaviour. This may explain why functional recovery obtained with intrastriatal DA neuron grafts is incomplete in both patients (Lindvall & Hagell, 2000) and animal models of Parkinson's disease (Annett et al., 1994; Winkler et al., 2000) .
In an ideal scenario, DA neuron grafts should be implanted into the SN to allow reconstruction along the entire nigrostriatal DA pathway. Attempts to re-establish a functional nigrostriatal connection from grafts placed in the SN, however, have so far met with limited success.
In rodent experiments intranigral DA neuron grafts have shown no or very limited growth of axons along the nigrostriatal pathway towards the striatum (Nikkhah et al., 1994a; Mendez et al., 1996; Bentlage et al., 1999; Mukhida et al., 2001) . Previous studies have suggested that the growth territory becomes non-permissive for outgrowing axons during post-natal development (Nikkhah et al., 1995; Bentlage et al., 1999) and that the supply of exogenous growth factors, such as glial cell line-derived neurotrophic factor (GDNF), may be used to overcome this obstacle Wilby et al., 1999) .
Interestingly, studies of neural transplants in other areas of the adult central nervous system have shown that immature neuroblasts or young post-mitotic neurons can retain the capacity to extend axons in a target-specific manner over large distances in adult recipients (Bjorklund et al., 1986; Wictorin et al., 1990 Wictorin et al., , 1991 Wictorin et al., , 1992 Li & Raisman, 1993; Isacson et al., 1995; Isacson & Deacon, 1996; Gaillard et al., 2007) . Therefore, the failure in previous studies to detect significant long-distance axon growth from intranigral DA neuron transplants could be due to the techniques used for graft implantation and visualization of the graft-derived axonal projections. Here, we have made use of donor tissue from a transgenic mouse in which green fluorescent protein (GFP) is driven by the tyrosine hydroxylase (TH) promoter (Sawamoto et al., 2001) and a microtransplantation approach that allows very precise implantation of small deposits of cells into the SN in adult mice. The GFP expression allows unequivocal identification of the transplanted DA neurons and their axonal projections with high sensitivity within the host brain, even in the presence of a residual nigrostriatal projection. Using these tools we show that fetal DA neuroblasts implanted into the SN of adult mice are capable of extending axons along the nigrostriatal trajectory and establish a terminal network in striatal and limbic forebrain areas that closely matches that seen in the intact animal. Moreover, we show that this axonal regrowth can be further enhanced by the addition of trophic support provided by over-expression of GDNF in the striatal target. Finally, results from testing of rotational behaviour in response to amphetamine treatment show that grafted DA neurons are capable of functional integration into the host basal ganglia circuitry when placed into the SN.
Materials and methods

Animals
Adult (25-35 g) female NMRI mice (Charles River) were housed on a 12 ⁄ 12 h light ⁄ dark cycle with ad-libitum access to food and water. All procedures were conducted in accordance with guidelines set by the Ethical Committee for the use of laboratory animals at Lund University (Malmö/Lunds djurförsöksetiska nämnd).
Ventral mesencephalon cell suspensions
Timed pregnant mice (day of vaginal plug designated as embryonic day 0.5) were generated by crossing wild-type NMRI females with transgenic (+ ⁄ )) males (mixed C57BL ⁄ 6-NMRI background) expressing GFP under the control of the TH promoter (Sawamoto et al., 2001) . At embryonic day 12.5, embryos were removed from pregnant mothers after lethal exposure to CO 2 and GFP + ⁄ ) and wildtype littermates were identified and separated under a fluorescence microscope. The VM was dissected free from each embryo as described previously (Dunnett & Björklund, 1992 , taking care to remove the meninges. Single-cell suspensions were prepared from GFP + ⁄ ) VM tissue as previously described (Nikkhah et al., 1994b . The cells were stored on ice during the transplantation procedure.
Surgical procedures
6-Hydroxydopamine lesions
Adult mice received a unilateral lesion of the nigrostriatal DA system through injection of 6-hydroxydopamine (6-OHDA) (Sigma; 1.6 lg ⁄ lL free base in 0.9% w ⁄ v NaCl with 0.2 mg ⁄ mL l-ascorbic acid) using a stereotaxic apparatus (Stoelting, Germany) and a 5 lL Hamilton syringe fitted with a fine glass capillary (external diameter 60-80 lm). A total of 1.5 lL was delivered to the SN at the following anterior ⁄ posterior (AP), medial ⁄ lateral (ML) and dorsal ⁄ ventral (DV) co-ordinates (mm) relative to bregma or the dural surface: AP, )3.0; ML, )1.2; DV, 4.5 (flat skull position). For all surgical procedures, induction and maintenance of anaesthesia was achieved using 2% isoflurance delivered as an inhalant in a 70:30 air/ N2O mixture.
Transplantation and glial cell line-derived neurotrophic factor delivery
The transplantation procedure was based on a microtransplantation protocol using glass capillaries attached to a 5 lL Hamilton syringe as described previously (Nikkhah et al., 2000) . At 4-6 weeks after the 6-OHDA lesion, intact (n = 5) or lesioned (n = 26) mice received a single 1.5 lL injection of fetal TH-GFP VM suspension (1 · 10 5 cells ⁄ lL) into the SN at the following stereotaxic co-ordinates: AP, )3.2; ML, )1.4; DV, )4.2 (flat skull position). Cells were injected over 2 min and the capillary was left in place for another 2 min before slow withdrawal. Ten of the 6-OHDA-lesioned animals also received intrastriatal injection of a recombinant adenoassociated viral (rAAV) vector carrying GDNF under control of the chicken b-actin (CBA) promoter (rAAV2 ⁄ 5-CBA-GDNF; infectious titer of 1.0 · 10 12 ) at the time of cell grafting, delivered at two sites (0.3 + 0.3 lL) on the dorso-ventral axis at the following co-ordinates: AP, +1.0; ML, )2.3; DV, )3.2, )2.2 (flat skull). A further three 6-OHDA-lesioned animals received rAAV2 ⁄ 5-CBA-GDNF but no graft as controls. The rAAV2 ⁄ 5-CBA-GDNF vector was constructed using inverted terminal repeats from a serotype 2 background and serotype 5 capsid proteins according to previously described procedures (Eslamboli et al., 2005) . Animals were killed (lethal dose of pentorbarbiturate, i.p.) at either 6 or 16 weeks (see Supporting information, Table S1 for animal grouping).
Retrograde labelling
For retrograde labelling, three of the 6-OHDA-lesioned grafted mice received an intrastriatal injection of rhodamine-labelled microbeads (Lumafluor, FL, USA) at 15 weeks after intranigral grafting at two sites on the dorso-ventral axis (100 nL ⁄ site) at the following co-ordinates: AP, +0.5; ML, )2.6; DV, )3.2 and )2.5 (flat skull position). The survival time after the microbead injections was 1 week.
Motor asymmetry in the amphetamine-induced rotation test
Amphetamine-induced rotation was performed in automated rotational bowls (AccuScan Instruments, Columbus, OH, USA) as described previously (Ungerstedt and Arbuthnott, 1970) . Mice received an injection of d-amphetamine sulphate (5 mg ⁄ kg, i.p.) at 3 weeks after 6-OHDA treatment. Full body rotations were recorded over a period of 60 min and data are expressed as net full body turns ⁄ min, with rotation towards the side of the lesion given a positive value. Animals displaying equal to 5 turns ⁄ min were selected as sufficiently impaired for inclusion in the rotational analysis. These animals were again tested using the same parameters at 8, 12 and 16 weeks after grafting.
Tissue processing and immunohistochemistry
Following a lethal dose of pentorbarbiturate (i.p.), animals were transcardially perfused with saline (0.9% w ⁄ v) followed by paraformaldehyde (4% w ⁄ v in 0.1 m phosphate-buffered saline). The brains were removed and post-fixed for a further 2 h in 4% paraformaldehyde and cryoprotected overnight in sucrose (25% w ⁄ v in 0.1 m phosphate-buffered saline) before being sectioned on a freezing microtome (Leica, Germany). Coronal or horizontal sections were collected in 12 series at a thickness of 30 lm.
Immunohistochemical procedures were performed as previously described in detail (Thompson et al., 2005) . Briefly, free-floating sections were incubated with primary antibodies overnight at room temperature (approx. 22°C) in an incubation solution of 0.1 m phosphate-buffered saline with potassium containing 5% normal serum and 0.25% Triton X-100 (Amresco, USA). Secondary antibodies were diluted 1 : 200 in phosphate-buffered saline with potassium with 2% normal serum and 0.25% Triton X-100 and applied for 2 h at room temperature. Detection of the antibody conjugates was achieved using either a peroxidase-based reaction followed by precipitation of diaminobenzidine (DAB) (Sigma) or conjugation of a fluorophore (either directly to the secondary antibody or with a streptavidin-biotin amplification step where necessary). Slide-mounted sections labelled with fluorescent markers were coverslipped with PVA-DABCO (Peterson, 1999) and DAB-labelled sections were dehydrated in alcohol and xylene and coverslipped with DePeX mounting media (BDH Chemicals, UK). The primary antibodies, species that they were raised in, clonality, supplier, catalogue number, immunogen used for production (recombinant full-length protein or peptide sequence and species) and dilution factors were as follows: rabbit polyclonal anti-calbindin D-28k (1 : 1000; Swant, Switzerland; Cat. no. CB38; recombinant fulllength protein, rat); rabbit polyclonal anti-DA-and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) (1 : 1000; Chemicon, Temecula, CA, USA; Cat. no. AB1656; CQVEMIRRRRPTPAM, human); rabbit anti-Girk2 (1 : 100; Alomone Labs, Jerusalem, Israel; Cat. no. APC-006; ELANRAEVPLSWSVSSKLNQHAELETEEEEKN-PEELTERNG, mouse); chicken (1 : 1000; Cat. no. ab13970) or rabbit (1 : 20 000; Cat. no. ab290) polyclonal anti-GFP (both Abcam, Cambridge; recombinant full-length protein, Aequorea victoria); and rabbit anti-TH (1 : 1000; Pel-Freeze Biologicals, Rogers, AR, USA; Cat. no. P40101-0; sodium dodecyl sulphate-denatured protein from pheochromocytoma, rat). Control experiments to confirm the specificity of the primary antibodies were as follows: calbindin D28k, immunohistochemistry on brain sections from calbindin D28k knockout mice; Girk2, pre-incubation of antibody with three-fold concentration of control immunogen prior to immunohistochemistry on mouse brain sections; DARPP-32, comparison with known mRNA expression pattern in adult mouse brain; GFP, immunohistochemistry on brain sections from wild-type mice; and TH, detection of 60 kDa TH protein through western blot using rat striatal lysate. For fluorescent labelling, the secondary antibodies were conjugated with cyanine (Cy)2, Cy3, Cy5 (Jackson ImmunoResearch, Westgrove, PA, USA) or biotin (Vector Laboratories, Burlingame, CA, USA); sections labelled with biotinconjugated antibodies were subsequently incubated (1 h) with Cy2-, Cy3-or Cy5-conjugated streptavidin (1 : 200; Jackson ImmunoResearch). For DAB labelling, biotin-conjugated goat anti-rabbit was used (Jackson ImmunoResearch) followed by incubation with peroxidaseconjugated streptavidin (Vectastain ABC kit, Vector Laboratories). No significant non-specific signal was generated from the secondary antibodies, as determined by control experiments where the primary antibody was omitted from the immunohistochemical procedure.
Imaging and schematics
All fluorescent images were captured using a DMRE confocal microscope (Leica) equipped with green helium ⁄ neon, standard helium ⁄ neon and argon lasers. The images are presented as collapsed reconstructions of optical sections captured every 2 lm on the z-axis over a depth of approximately 20 lm within the tissue section, at a scan rate of 200 Hz, a resolution of 1024 · 1024 and with 2x oversampling for both the line and frame acquisition modes. The signal from each fluorophore was captured sequentially and the emission filter was adjusted to capture only the peak (< 50 nm) emission in order to avoid off-target bleed-through from other fluorophores. To provide low-magnification overviews of graft-derived fibre innervation throughout the host brain (Fig. 2) , GFP+ fibre patterns were accurately traced (Canvas version 9.04, Deneba Systems, USA) over digital photomontages of coronal sections immunohistochemically (DAB) labelled for GFP, using a Leica microscope with bright-field illumination and a dark-field filter. The low-magnification images of GDNF immunohistochemistry in horizontal sections in Fig. 6 were acquired using a high-resolution scanner (Scanscope GL) and Imagescope v8.2 software. The objectives and numerical apertures used for all photographs are stated in the figure legends.
Cell counting
The number of DA neurons contained in each graft was estimated through extrapolation of the total number of GFP+ cells, detected by immunohistochemistry (DAB), counted in every sixth tissue section. The method of Abercrombie (1946) was used to correct for the possibility of double-counting due to cells spanning more than one tissue section.
Statistics
A one-way anova (with Dunnett's correction) was performed at each time-point in order to assess the significance of differences in mean amphetamine-induced rotational scores between each group. A maximum P value of 0.05 was assigned to indicate statistical significance. Animals with no surviving graft, or significantly misplaced grafts, were excluded from the analysis (see supporting Table S1 ).
Results
Structure and placement of intranigral grafts
At killing (6 and 16 weeks after transplantation) the grafts appeared as well-demarcated round or oval cell clusters located within, or immediately adjacent to, the SN, identifiable by their content of GFP+ neurons (Figs 1a, 2g and 3a) . In the animals not treated with GDNF, the surviving grafts (16 ⁄ 21; 3 ⁄ 5 in intact hosts and 13 ⁄ 16 in lesioned hosts) contained on average 1415 ± 268 GFP+ DA neurons (1 ± 0.2% of total cells grafted), which corresponds to about 15% of the number of DA neurons normally present unilaterally in the mouse SNventral tegmental area (VTA) complex (Bjorklund & Dunnett, 2007) . Double immunostaining showed that the majority of the GFP+ cells in the grafts were also TH+ (Fig. 1b) , which is consistent with the previous observation that > 95% of the GFP-expressing neurons in intrastriatal grafts of the VM taken from the TH-GFP mice are also TH+ (Thompson et al., 2005) . The two principal DA neuron types normally present in the SN-VTA region, i.e. the TH+ ⁄ Girk2+ A9 neurons of the SN and the TH+ ⁄ calbindin+ A10 neurons of the VTA, were both present ( Fig. 1c and d) and were arranged such that the Girk2+ neurons were distributed predominately within the periphery of the grafts with the calbindin+ neurons closer to the centre. In the host midbrain, some TH+ neurons remained in the SN, whereas the VTA remained relatively spared on the 6-OHDA-injected side (Fig. 1a) .
Extension of axons along the nigrostriatal pathway
The GFP reporter allowed us to trace the graft-derived dopaminergic axonal outgrowth within the host brain with a sensitivity that permitted the detection of individual varicose terminal branches within the innervated territories. In 6-OHDA-lesioned mice, GFP+ fibres were found to extend over long distances along the nigrostriatal pathway and medial forebrain bundle (MFB) to give rise to widespread innervation in the striatal and limbic areas of the forebrain Reconstructing the nigrostriatal pathway 627 (Fig. 2) . At 6 weeks post-grafting, GFP+ fibres could be detected throughout the normal target fields for A9 ⁄ A10 DA neuron cell groups, including the striatum, nucleus accumbens, bed nucleus of the stria terminalis, amygdala and septum (Fig. 2b-e) , reaching as far rostrally as the frontal cortex and olfactory tubercle, at a distance of approximately 6-7 mm from the graft (Fig. 2b, level 1) . Graft-derived fibres were also found in the host substantia nigra pars reticulata (Fig. 2g) and the ipsilateral and contralateral pontine nuclei, caudal to the graft (not shown). By 16 weeks, this innervation pattern had expanded further (Fig. 3) to cover larger areas of the forebrain including an elaborately ramified fine-beaded terminal network that extended throughout large parts of the striatum (Fig. 3b, c and e) . The degree of innervation was greatest in the ventral aspects of the striatum and became less dense dorsally, such that few fibres were seen in the dorsal and rostral parts of the striatum.
As seen in sections cut in the horizontal plane ( Fig. 3b and d) , the outgrowth of GFP+ fibres from the graft cell cluster was highly polarized and directed along the trajectory normally carrying the axons of the nigrostriatal and mesolimbic DA pathways. The GFP+ axons extending from the graft coursed as a tightly clustered fibre bundle within the medial aspect of the internal capsule and the adjoining MFB (Figs 2f and 3b and d) . At the level of the globus pallidus, the fibres diverged in rostral, lateral and caudal directions towards multiple forebrain target areas. On reaching the border of the caudate putamen, the elongated projections abruptly branched to give rise to a highly elaborated terminal network within the striatal grey matter (Fig. 3e) , whereas others continued further rostrally within the white matter bundles of the internal capsule.
Double staining for TH and GFP showed that graft-derived GFP+ ⁄ TH+ fibres were often intermingled with the spared hostderived GFP) ⁄ TH+ axons, although they were rarely seen to project in apposition to each other (Figs 3f and g, and 4b-d). Closer inspection of the GFP ⁄ TH double-stained sections, however, revealed that the central core of the GFP+ fibre bundle did not overlap with the trajectory of the intrinsic nigrostriatal pathway but coursed further laterally in a position corresponding to the reciprocal striatonigral pathway. To explore this possibility we used an antibody recognizing DARPP-32, which is selectively expressed in the striatal projection neurons, to visualize the striatonigral axons in combination with GFP. The GFP ⁄ DARPP-32 double-stained sections revealed that the central portion of the GFP+ fibre bundle ran within the DARPP-32+ axon bundle, with many of them in apposition to the surface of the DARPP-32+ fibres (Fig. 4e-g ). The Girk2+ (red) ⁄ GFP+ double-labelled cells were located preferentially in the periphery of the grafts and had the typical large and angular morphology indicative of the A9 DA neuron type. The boxed area in (c) is shown as single colour channels (c¢ and c¢¢; arrows identify a large Girk2+ ⁄ GFP+ neuron in the periphery of the graft and a smaller Girk2) ⁄ GFP+ neuron). The calbindin+ ⁄ GFP+ cells were located predominately towards the centre of the grafts and the small rounded morphology is consistent with an A10 DA neuronal identity. The boxed area in (d) is shown as single colour channels (d¢ and d¢¢¢; arrow identifies a calbindin+ ⁄ GFP+ neuron; arrowhead identifies a larger calbindin) ⁄ GFP+ neuron towards the periphery of the graft). SNr, substantia nigra pars reticulata. Objective and numerical apertures: a, 10x ⁄ 0.4 (montage of three separate images arranged on the horizontal plane); b-d, 20x ⁄ 0.7. Scale bars: a, 500 lm; b-d, 100 lm.
The survival of the transplanted DA neurons, as well as the extent of fibre outgrowth into the host, was clearly influenced by the presence or absence of the intrinsic dopaminergic projections. In non-lesioned mice, the grafts (n = 3) contained on average 909 ± 187 GFP+ neurons, i.e. approximately half the number seen in the 6-OHDAlesioned mice (1566 ± 333; n = 13), and the GFP+ axonal outgrowth along the nigrostriatal pathway was less dense. In these animals innervation was limited to some scattered fibres in the amygdala and the most caudal aspects of the striatum. Further rostrally, single GFP+ fibres were detected in the olfactory tubercle and the medial frontal and perirhinal cortex but the overall density and extent of the GFP+ innervation in these forebrain areas were much less than in the 6-OHDA-lesioned hosts (compare coronal sections in Fig. 2a with those in Fig. 2b) .
Identification of the projecting neurons by retrograde tracing
To identify the cells of origin of the outgrowing axons we injected rhodamine-labelled microbeads as a retrograde axonal tracer into the striatum of three grafted 6-OHDA-lesioned mice at 15 weeks Fig. 2 . Patterns of dopaminergic fibre outgrowth from intranigral VM grafts. GFP+ fibre patterns in coronal sections from representative intact and 6-OHDAlesioned mice with intranigral grafts (a and b; 6 weeks survival). Substantially fewer fibres were seen in the forebrain of intact hosts (a), relative to lesioned animals (b), particularly at the level of the striatum. Dark-field photographs of GFP+ fibres, as revealed through immunohistochemistry, depict: graft placed in the nigra with fibres projecting ventrally into the pars reticulata (g); fibres coursing within the internal capsule, parallel to the MFB in a position corresponding to the lesioned host nigrostriatal pathway (f ); fibres at two levels of the striatum, including more sparsely at a rostral level (c) and also more extensively at a caudal level (e); and olfactory tubercle, where the bulk of fibres were seen at the more rostral levels examined (d). *, injection tract; AC, anterior commissure; Amy, amygdala; CPu, caudate putamen; FM, forceps minor; H, hippocampus; IC, internal capsule; ml, medial lemniscus; NAc, nucleus accumbens; NSP, nigrostriatal pathway; OT, olfactory tubercle; Pir, piriform cortex; S, septum; SN, substantia nigra; SNr, substantia nigra pars reticulata; T, transplant. Objective and numerical apertures: c, 20x ⁄ 0.6; b-d, 10x ⁄ 0.4. Scale bars: c and d-g, 200 lm. Fig. 3 . Anatomical reconstruction of the nigrostriatal pathway. Dark-field photomontages illustrating the pattern of graft-derived GFP+ fibre outgrowth in horizontal sections from a representative 6-OHDA-lesioned animal (16 weeks post-grafting) (a). The approximate dorso-ventral level of each section (1-3) is indicated in the parasagittal schematic. The trajectory and structure of the GFP+ fibre outgrowth matched the intrinsic system well. The GFP+ outgrowth was highly polarized, exiting the rostral pole of the graft and coursing parallel to the MFB en route to the forebrain (b). Boxed areas in (b) illustrate in (d) elongated fibres projecting through the nigrostriatal pathway and in (c) the highly ramified fibre patterns established in the striatum. The transition between these distinct patterns of fibre morphology was seen to occur abruptly at the palladial-striatal border (e). Dual immunohistochemistry for TH and GFP (red and green, respectively, in f and g) revealed that the grafted (GFP+ ⁄ TH+; arrowheads) fibres commonly shared the same structure and territory as the host (GFP) ⁄ TH+; arrows) fibres throughout the nigrostriatal pathway (f ) and within the striatum (g). AC, anterior commissure; CPu, caudate putamen; GP, globus pallidus; IC, internal capsule; T, transplant. Objective and numerical apertures: a-d, 20x ⁄ 0.6; e, 10x ⁄ 0.4; f and g, 20x ⁄ 0.7. Scale bars: b, 500 lm; c and d, 100 lm; e, 200 lm; f and g, 200 lm. Fig. 4 . Anatomical relationship between graft-derived dopaminergic fibres and local fibre pathways in the host brain. Immunohistochemistry for TH (red) illustrates dopaminergic nigrostriatal projections at a ventral level on the intact (a) and 6-OHDA-lesioned (b-d) sides of the brain, as seen in the horizontal plane. Dopaminergic fibres originating from the graft (GFP+ ⁄ TH+; arrows in c) were often intermingled with remaining host fibres (GFP) ⁄ TH+; arrowheads in c) along the nigrostriatal pathway (b-d). Parallel sections stained for GFP and DARPP-32 illustrate the pattern of graft-derived dopaminergic outgrowth (green) relative to that of the descending striatonigral projections (red; e-g, approximate position of these panels shown as dashed boxes in b). The GFP+ axons were seen to precisely follow the trajectory of DARPP-32+ fibre bundles throughout the projection territory (e) and individual GFP+ and DARPP-32+ fibres were often observed in apposition to one another, coursing in parallel trajectories over long distances (f and g). CPu, caudate putamen; GP, globus pallidus; mfb, MFB. Objective and numerical apertures: a-g, 20x ⁄ 0.6 (a, b, e and f are photomontages of multiple images). Scale bars: a and b, 500 lm; c and d, 50 lm; e, 100 lm; f, 150 lm. post-transplantation. Figure 5a illustrates the placement of the microbeads relative to the GFP+ graft in a representative animal. Bead-labelled GFP+ cells were found in all three grafts. When examined in Girk2-stained sections, nine of the 10 bead-labelled cells analysed were also Girk2+ and had a large, angular morphology (Fig. 5b) , suggesting that the axons innervating the striatum were primarily derived from the A9 DA neurons within the grafts. The single bead-labelled Girk2) cell observed was comparatively smaller and with a distinctly more spherical morphology (Fig. 5c) .
Stimulation of graft-derived fibre outgrowth by over-expression of glial cell line-derived neurotrophic factor
At the time of intranigral cell grafting, a subset of the 6-OHDAlesioned animals received an intrastriatal injection of a rAAV vector encoding GDNF, driven by a constitutive (CBA) promoter (rAAV-CBA-GDNF). Immunohistochemistry for GDNF protein 16 weeks later showed robust GDNF expression throughout the striatum and overlying cortex (Fig. 6a) . We also observed anterograde transport of GDNF along the striatopallidal and striatonigral pathways towards the globus pallidus, entopeduncular nucleus and SN, and also in areas innervated by the transduced fronto-parietal cortex, most conspicuously in the thalamus (boxed area in Fig. 6a) . Closer inspection revealed a diffuse GDNF staining along the entire fibre trajectory connecting the striatum with the graft site and also within the graft itself (Fig. 6a) .
Over-expression of GDNF in the host striatum had a clear impact on both the survival and overall outgrowth of dopaminergic fibres from the intranigral grafts (compare Figs 3 and 6) . Surviving grafts were found in 10 ⁄ 10 GDNF-treated animals (as compared with 16 ⁄ 21 animals without GDNF). Similar to the non-GDNF-treated mice Immunohistochemistry revealed a robust level of GDNF throughout the striatum and overlying cortex; and also within the efferent targets of striatal and cortical projection neurons, including globus pallidus and SN, as well as thalamus (a). The pattern of GFP+ fibre outgrowth from intranigral grafts in GDNF-treated animals is illustrated in dark-field photomontages of horizontal sections through a representative animal (b). The dorso-ventral level of each section (1-3) is indicated on the schematic parasagittal section. The GFP+ fibres extended from the graft throughout the nigrostriatal pathway to innervate various forebrain regions, including the striatum, which contained areas of dense innervation from a highly ramified network of GFP+ fibres (b, d and e) . Although the majority of GFP+ fibres projected within the normal territory of the nigrostriatal pathway, a subset of fibres in the GDNF-treated animals were seen to depart from this pathway to innervate GDNFexpressing nuclei in the dorsal thalamus (c). AC, anterior commissure; Amy, amygdala; CPu, caudate putamen; Cx, cortex; GP, globus pallidus; FR, fasciculus retroflexus; H, hippocampus; IC, internal capsule; MD, mediodorsal thalamic nuclei; NAc, nucleus accumbens; Pir, piriform cortex; Th, thalamus; T, transplant; V, ventricle. Objective and numerical apertures: b-e, 20x ⁄ 0.6 (b, d and e are photomontages of multiple images). Scale bars: b, 1 mm. (Fig. 1) , the grafts occurred as discrete cell deposits within or immediately adjacent to the host SN (Fig. 7) . The grafts in the GDNFtreated animals contained, on average, greater numbers of DA neurons (2747 ± 417 GFP+ cells) than those in the non-GDNF-treated group (1566 ± 333). The composition of DA neuronal subtypes within the grafts appeared similar, however, with approximately equal numbers Reconstructing the nigrostriatal pathway 633 of Girk2-and calbindin-expressing GFP+ cells (Fig. 7b-f ) . The spatial distribution of GFP+ fibres throughout the striatum was similar in both groups but the density of the innervation was markedly increased in the GDNF-treated animals (cf. Figs 3a and 6b, d and e) , particularly in the part of the striatum bordering on the globus pallidus (see Supporting information, Fig. S1 ). In the GDNF-treated animals the graft-derived fibre outgrowth closely resembled the structure of the intrinsic DA projection system, as was the case for grafted animals without GDNF treatment. However, there were some notable differences. Whereas, in all animals without GDNF, the GFP+ fibre outgrowth was restricted to the normal boundaries of the nigrostriatal fibre trajectory, in the GDNF-treated animals a subset of GFP+ fibres exited the nigrostriatal pathway towards the GDNF-expressing area in the medial thalamus (Fig. 6b and c) . In addition, we observed signs of localized sprouting of GFP+ fibres, particularly within the globus pallidus, not present in animals without GDNF treatment. This was also evident at the level of the graft, where there was a greater degree of localized neuritic outgrowth in the GDNF-treated animals.
Functional impact of intranigral grafts
The functional effect of the intranigral VM grafts was assessed by amphetamine-induced rotation before and at 8, 12 and 16 weeks after grafting. All mice included in the study showed an amphetamineinduced rotational asymmetry of equal to 5 turns ⁄ min prior to grafting. Both groups of grafted animals showed a marked improvement in rotational asymmetry, relative to the non-grafted controls, Fig. 7 . Placement and structure of intranigral grafts in GDNF-treated animals. Grafts in animals over-expressing GDNF were found within or immediately adjacent to the SN (a) (16 weeks post-grafting). Immunohistochemistry for TH (red) and GFP (green) illustrates graft placement in a representative animal (GFP+ ⁄ TH+), in relation to the intrinsic DA neurons (GFP) ⁄ TH+). Expression of calbindin (red) and Girk2 (blue) identifies major midbrain DA cell groups (A8, A9 and A10) within the host and also in the GFP+ graft (b). As in the non-GDNF-treated animals the grafts contained similar numbers of calbindin+ A10 neurons (arrowheads, c-f ), typically in the centre of the graft, and Girk2+ A9 neurons, distributed predominately within the periphery of the graft (arrows, c-f ). T, transplant. Objective and numerical apertures: a and b, 20x ⁄ 0.7 (photomontage of three images arranged on the horizontal plane); c-f, 63x ⁄ 1.2w. Scale bars: a, 500 lm; c, 50 lm.
which was evident by 8 weeks after grafting (Fig. 8) . The grafted animals that received intrastriatal injections of rAAV-GDNF showed a sustained and consistent improvement and the mean rotational score for this group was significantly reduced, when compared with the lesion control group at 12 weeks (F 4,21 = 8.811, P < 0.01) and 16 weeks (F 4,21 = 4.505, P < 0.05) post-grafting, to almost complete recovery in motor asymmetry. The grafted animals without GDNF treatment showed more variable responses at these longer time-points and the reduction in mean rotational score did not reach statistical significance when compared with the lesion control group at 12 weeks (F 4,21 = 8.811, P > 0.05) and 16 weeks (F 4,21 = 4.505, P > 0.05). Non-grafted animals that received intrastriatal rAAV-GDNF alone did not show any sign of functional recovery.
Discussion
The results show for the first time that fetal mouse DA neuroblasts allografted into the host SN are able to generate a new nigrostriatal pathway in adult 6-OHDA-lesioned mice. Axonal outgrowth along the nigrostriatal trajectory has previously been observed from xenogenic transplants, i.e. from human or pig cells grafted to the striatum or SN in lesioned adult rats (Wictorin et al., 1992; Isacson et al., 1995; Isacson & Deacon, 1996) . In these studies antibodies recognizing human or pig, but not rat, neurofilaments were used to visualize the graft-derived neurites. Given the failure in earlier studies to obtain similar regrowth of graft-derived axons from cells obtained from fetal rodent donors (Mendez et al., 1996; Bentlage et al., 1999; Mukhida et al., 2001) , this raised the possibility that axonal growth inhibitory factors may operate poorly between species, i.e. that the cells derived from human or pig donors may not recognize the growth inhibitory molecules present along the growth trajectory in adult hosts. The present data show that this is not the case.
The use of GFP as a surrogate marker of DA neuronal identity has allowed us to unambiguously detect graft-derived dopaminergic outgrowth patterns in mice with partial lesions of the intrinsic nigrostriatal pathway. In earlier allografting studies the investigators have had to rely on TH immunohistochemistry in order to visualize graft-derived axons and thus there was no basis for distinguishing between DA fibres of graft and host origin. This made it necessary to perform the grafting experiments in animals with complete lesions of the nigrostriatal pathway, achieved by injection of 6-OHDA directly into the MFB. If axonal growth along the nigrostriatal pathway is facilitated by the presence of spared DA axons, animals with complete lesions may not provide the right conditions for regrowth to occur. Furthermore, there is a risk that injection of high doses of the toxin directly into the MFB may cause non-specific damage at the injection site and disruption of axonal conduits along the growth trajectory. The use of fine glass capillaries to inject low doses of 6-OHDA directly into the SN, as done here, minimizes non-specific damage to local fibre tracts and may thus provide more favourable conditions for regrowth.
The axonal projection from the grafted DA neuroblasts was remarkably specific. The outgrowth of GFP+ axons from the graft cell cluster was clearly polarized; the vast majority of the GFP+ fibres exited the graft at the rostral pole and were oriented rostrally, along the intrinsic nigrostriatal fibre trajectory and the adjacent MFB. Moreover, the ramification of the fibres and the distribution of the GFP+ terminals in the striatal, limbic and cortical areas closely matched the projection patterns of the intrinsic midbrain DA neurons. The axons coursing along the nigrostriatal pathway, arranged in a loose nonramifying bundle, were seen to branch profusely at the border between the globus pallidus and caudate putamen, suggesting a direct influence of local cues on the ability of the growing axons to establish a new terminal innervation network in the denervated target. This is further supported by the observation that the extension and terminal distribution of the graft-derived GFP+ fibres was much more restricted in the non-6-OHDA lesioned hosts where the intrinsic DA projections were left intact. At the level of the SN, the projection of GFP+ dendrites into the SN pars reticulata highlights that this component of the normal circuitry can also be at least partially re-established through homotopic placement of the grafted DA neurons.
These observations suggest that axonal outgrowth and terminal innervation patterns from the grafted neurons are quite specifically regulated by interactions with the host growth environment. During normal development the growth of axons from the developing midbrain DA neurons rostrally along the MFB is determined by a combination of local directional cues, associated with the growth substratum, and more long-distance chemoattractive influences present along the MFB and in the striatal primordium (Nakamura et al., 2000; Gates et al., 2004) . Similar mechanisms may also be involved in axonal pathfinding in the adult brain. Axonal guidance factors, such as Netrins, Slits and Ephrins, have been implicated in the axonal pathfinding of midbrain DA neurons during development (Yue et al., 1999; Sieber et al., 2004; Lin & Isacson, 2006) , although it remains unclear whether any of these signalling mechanisms function in DA axon growth or regeneration in the adult animal.
A particularly interesting possibility is that host axons present along the growth trajectory, either DA axons spared by the 6-OHDA lesion or the axons of the reciprocal striatonigral projection, may assist the regrowing axons to reach their appropriate targets. In developing animals it is known that pioneer axons (that form connections when the distances are short), or early developing axons that grow in the opposite Fig. 8 . Functional impact of intranigral grafts. The rotational response to amphetamine (5.0 mg ⁄ kg, i.p.) was assessed prior to grafting and at 8, 12 and 16 weeks after grafting. Intact control animals (filled circles; n = 7) did not display any significant rotational bias throughout the test period. The 6-OHDAlesioned animals (open circles; n = 6) and GDNF-treated but non-grafted 6-OHDA-lesioned animals (filled squares; n = 3) displayed a prominent rotational bias (10-15 turns ⁄ min) that was maintained at all time-points. Animals that received intranigral VM grafts alone (open triangles; n = 5) or in combination with GDNF (filled triangles; n = 5), showed significant recovery in motor behaviour that was most pronounced and consistent in the animals that received grafts in combination with GDNF (*P < 0.05 compared with 6-OHDA-lesioned controls; one-way anova at each time-point).
direction from the target area, can act as guides for the developing axons towards their targets (Klose & Bentley, 1989; McConnell et al., 1989 McConnell et al., , 1994 Lin et al., 1995; Hidalgo & Brand, 1997; Molnar et al., 1998; Pittman et al., 2008) . Our observations suggest that similar mechanisms could also operate during axonal regrowth from grafted fetal neurons. Close inspection of the TH ⁄ GFP double-stained sections showed that graft-derived GFP+ fibres were intermingled with the spared TH+ axons along the nigrostriatal pathway and the MFB, which raises the possibility that the spared axons could promote axonal regrowth by the secretion of diffusible chemoattractant or growth-promoting factors, such as the neurotrophic factor brain-derived neurotrophic factor (Bustos et al., 2004) , known to be produced by the host DA neurons. Along these lines, previous studies have suggested that increased growth support along the nigrostriatal pathway provided by tissue bridge grafts (Brecknell et al., 1996; Wilby et al., 1999; Chiang et al., 2001) , or a permissive environment provided by kainic acid lesions (Zhou et al., 1996) , can facilitate the growth of DA axons along the nigrostriatal pathway. The most striking association, however, was with the axons of the host striatonigral pathway where the outgrowing GFP+ DA fibres were seen to course in apposition to the DARPP-32+ fibre bundles. Interestingly, the medium-sized projection neurons are known to be the prime source of GDNF in the striatum (Trupp et al., 1997; Barroso-Chinea et al., 2005) . Striatum-derived GDNF, transported and expressed along the striatonigral pathway, may thus be able to create a growth-permissive environment for the graft-derived dopaminergic axons. GDNF is known to exert its growth-stimulating effect by interaction with the GDNF receptor, GRFa1, which is expressed by the developing DA neurons. Recent data suggest that the GRFa1 receptor, when combined with GDNF, can indeed act as an attractant guidance molecule, as well as a cell-adhesion factor, for axons that express the GDNF coreceptor Ret (Ledda et al., 2002; Paratcha & Ledda, 2008) .
Glial cell line-derived neurotrophic factor has previously been shown to act as a powerful chemoattractant for outgrowing DA axons, both in organotypic coculture (Schatz et al., 1999; Jaumotte & Zigmond, 2005) and in vivo from intrastriatal or intranigral VM grafts (Rosenblad et al., 1996; Wang et al., 1996; Wilby et al., 1999; Redmond et al., 2009) . Moreover, supply of exogenous GDNF to the striatum has been shown to provide a stimulus for axonal regeneration in the lesioned nigrostriatal system (Rosenblad et al., 1998; Brizard et al., 2006) . Based on these observations we investigated the possibility of boosting the long-distance axonal regrowth from intranigral DA neuron grafts by over-expression of GDNF in the striatum. Within the striatum, the cells most efficiently transduced by the AAV vector are the striatal projection neurons. As a result, GDNF is not only expressed within the striatum but is also transported along the striatopallidal and striatonigral pathways and delivered along its trajectory to the downstream striatal targets, including the globus pallidus, entopeduncular nucleus and SN. This anterograde transport made it possible for GDNF to act synergistically at three sites: in the SN to improve DA neuron survival at the graft site (by about 75%); along the axonal growth trajectory to promote the extension of the outgrowing axons towards the striatum; and locally in the striatum to provide a more widespread reinnervation of the striatal target. In these animals the more extensive striatal reinnervation was accompanied by a more consistent and near-complete reversal of motor asymmetry in the amphetamine rotation test. Although an important proof-ofprinciple demonstration of integration at the functional level, it should be noted that amphetamine-induced rotation is one of the least stringent tests of behavioural recovery in transplantation experiments. Further studies, including tests of spontaneous motor function, will be needed to provide a more in-depth analysis of the potential for behavioural recovery that can be achieved through intranigral grafting.
The present data suggest that GDNF can act as a diffusible attractant to promote the regrowth of graft-derived axons over larger distances. This is further supported by the observations in mice where GDNF was delivered to parts of the thalamus (by anterograde axonal transport from cortical projection neurons transduced by the AAV-GDNF vector). In these animals the regrowing graft-derived fibres were seen to deviate from the nigrostriatal bundle to form a separate branch directed towards the area of GDNF expression. As these areas of the thalamus normally receive a sparse DA innervation (Garcia-Cabezas et al., 2008) this does not necessarily represent an anomalous projection but rather an increased innervation of a normally sparsely innervated target, similar to that observed after the addition of exogenous GDNF in slice cultures (Jaumotte & Zigmond, 2005) .
In conclusion, the present results demonstrate for the first time the ability of intranigral DA neuron allografts to extend axons along the nigrostriatal pathway and establish an extensive terminal network in striatal and limbic forebrain regions, with a distribution that closely matches that seen in the intact animal. The grafts contained the normal complement of A9 (nigral, Girk2+) and A10 (VTA, calbindin+) neuronal subtypes, and the retrograde tracing experiment indicates that graft neurons projecting to the striatum were of the correct, nigral phenotype. These data suggest that DA neuron transplants can achieve a level of circuitry reconstruction that has hitherto been possible to obtain with DA neuron allografts only in neonatal recipients. The implication of these findings is two-fold. First, the results extend earlier observations, obtained in other parts of the central nervous system (Bjorklund et al., 1986; Wictorin et al., 1991; Li & Raisman, 1993; Gaillard et al., 2007) , showing that the adult brain retains a capacity for pathway reconstruction and repair that is much greater than previously realized, and that grafted fate-committed neuroblasts are also capable of expressing their inherent capacity to grow long-distance, targetspecific projections in the lesioned adult central nervous system. Second, the results suggest that the current approach to DA neuron replacement in Parkinson's disease, based on ectopic grafting to the striatum, may be developed into a technique that will allow more complete circuitry reconstruction from neurons grafted homotopically to the nigra itself. This sets a new standard for DA neurons derived from stem cells, i.e. to express not only a midbrain dopaminergic phenotype but also to possess the capacity to reconstruct the nigrostriatal pathway when implanted homotopically into the host SN.
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